Skip to content

Effect of puta in Abharaka marana w.s.r. to Madhumeha ( Type 2 DM)

EFFECT OF PUTA IN ABHRAKA MARANA W.S.R. TO MADHUMEHA ( TYPE-2 DM )

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/10/006281
Enrollment
60
Registered
2015-10-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- MADHUMEHA (TYPE-2 DM)

Interventions

Intervention1: More number of Puta ie 10 Puti Abhraka Bhasma: 187.5 mg with Triphala Ghana 250 mg twice a day for 4 weeks with 2 weeks follow up Control Intervention1: Less number of Puta ie 3 Puti Ab

Sponsors

Institute for Post Graduate Teaching and Research in Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Both the sexes having Age between 30 years to 60 years Patients having classical symptomatology of Madhumeha (Prabhutamutrata, Avilamutrata etc) Symptoms of Diabetes (Polyuria, Polydipsia, Polyphagia and Weight loss) Patients having Blood sugar Fasting Blood Sugar >= 126 mg/dl Post Prandial Blood Sugar >= 200 mg/dl

Exclusion criteria

Exclusion criteria: Age below 30 and above 60 years. Patients of Diabetes Mellitus receiving Insulin. Malignant and accelerated Hypertension. Patients having chronic complications of Diabetes Mellitus a.Microvascular: Retinopathy, Neuropathy, & Nephropathy. b.Macrovascular: Coronary artery disease, Peripheral vascular disease & Cerebro-vascular disease. c.Other chronic debilitating diseases like STD etc. 5.Pregnant women. 6.Lactating mothers. 7.Secondary Diabetes mellitus. 8.Patients of any other severe illness. 9.Severe Iron deficiency anemia with Hb% less than 7mg/dl

Design outcomes

Primary

MeasureTime frame
It is expected that the trial drugs will exert a significant action over classical symptomatology of Madhumeha (Prabhutamutrata, Avilamutrata)Timepoint: up to 8 weeks

Secondary

MeasureTime frame
It will help to live diabetic patient more healthy and without complicationsTimepoint: Up to 4 weeks

Countries

India

Contacts

Public ContactDr Prashant Bedarkar

Institute for Pst Graduate Teaching and Research in Ayurveda Jamnagar

drprashantbedarkar@gmail.com08128217370

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026